FATE THERAPEUTICS INC Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FATE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FATE THERAPEUTICS INC for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Option Exercise | A | 21.99 | 219,000 | 4,815,810 | 219,000 | |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Grant | A | 0.00 | 66,000 | 0 | 419,969 | 354 K to 420 K (+18.65 %) |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Option Exercise | A | 21.99 | 90,000 | 1,979,100 | 90,000 | |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Sell | S | 20.69 | 5,700 | 117,947 | 86,058 | 91.8 K to 86.1 K (-6.21 %) |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Grant | A | 0.00 | 25,000 | 0 | 91,758 | 66.8 K to 91.8 K (+37.45 %) |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Option Exercise | A | 21.99 | 90,000 | 1,979,100 | 90,000 | |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 20.72 | 5,700 | 118,085 | 99,518 | 105.2 K to 99.5 K (-5.42 %) |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Grant | A | 0.00 | 25,000 | 0 | 105,218 | 80.2 K to 105.2 K (+31.17 %) |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | A | 21.99 | 90,000 | 1,979,100 | 90,000 | |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 20.70 | 5,700 | 117,986 | 143,091 | 148.8 K to 143.1 K (-3.83 %) |
| Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Grant | A | 0.00 | 25,000 | 0 | 148,791 | 123.8 K to 148.8 K (+20.20 %) |
| Jan 02 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | M | 2.90 | 25,000 | 72,500 | 98,800 | |
| Jan 02 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 20.34 | 100 | 2,034 | 123,791 | 123.9 K to 123.8 K (-0.08 %) |
| Jan 02 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 19.49 | 24,900 | 485,393 | 123,891 | 148.8 K to 123.9 K (-16.73 %) |
| Jan 02 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Buy | M | 2.90 | 25,000 | 72,500 | 148,791 | 123.8 K to 148.8 K (+20.20 %) |